Hutch News
Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
September 19, 2022
Machine learning identifies biomarkers that predict a patient’s response to immunotherapy
From the Gujral Lab, Human Biology Division
CD133 auto-antibodies shine a light on early-stage small cell lung cancer
From the Dr. Paul D Lampe, Dr. Christopher Li, and Dr. A McGarry Houghton Labs, Cancer Epidemiology, Prevention and Control and Cancer Immunology Programs, Cancer Consortium.
Dr. Yingye Zheng named fellow of American Statistical Association
Honored for work to develop biomedical decision tools
New protocols, precision approaches ahead for lung cancer
Hutch researchers launch liquid biopsy study; large biomarker protocol publishes, providing ‘roadmap’ for treatment of metastatic patients
Artificial intelligence and cancer
New study tests ability of natural language processing to search lung cancer patients’ records for treatable mutations
Washington’s Andy Hill Cancer Research Endowment awards $1.5M to 3 Fred Hutch researchers
Scientists will use funds to expand research in graft-vs.-host disease, chemoprevention and cancer immunology
H. pylori test hints at risk factor for stomach cancer
Pilot study suggests specific strain of bacteria may be found more often in East Asian patients with stomach cancer
Dr. James Dai receives $2.1M NCI grant for cancer biomarker research
Biostatistician plans to use funds to develop statistical models to further precision cancer prevention and treatment
Glory's gift: Colon cancer patient's enduring legacy
A young woman’s resolve to help find a better way to detect colon cancer led to a years-long relationship between her family and a researcher across the country